Cargando…
Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection
Organ transplantation is the optimal treatment for patients with end‐stage diseases. T cell activation is a major contributing factor toward the trigger of rejection. Induction therapy with T cell depleting agent is a common option but increases the risk of severe systemic infections. The ideal ther...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472007/ https://www.ncbi.nlm.nih.gov/pubmed/36176616 http://dx.doi.org/10.1002/btm2.10316 |